What is CAI's market cap?

$9.39B, based on the Nov 4 close of $33.22.

What is CAI's P/E ratio?

89.3× trailing-twelve-month earnings of $105.14M.

Does Caris Life Sciences pay a dividend?

No regular cash dividend has been paid in the last year.

How much of CAI is sold short?

13.6M shares, 12.5% of float, as of Oct 15, 2026.

What sector is CAI in?

Healthcare, in the Medical Labs industry.

NASDAQ · CAIHealthcareMedical Labs

Caris Life Sciences, Inc. Common Stock (CAI)

$33.22+1.13%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$33.22▲ 6.54% in range

Nov 4, 2025Low $14.55 · High $36.14Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Caris Life Sciences closed at $33.22 on Nov 4, up 1.13%, 8.1% below its 52-week closing high. Volume of 4.1M shares was 1.19× its 20-day average (close to normal).

Split-adjusted performance: +21.0% over one month, +73.7% over six months, +11.0% over one year.

In the quarter ended Jun 30, 2026, revenue was $263.71M, up 45.4% from a year earlier, with a net margin of -0.2%.

Short interest was 13.6M shares at the Oct 15 settlement, down 2.2% from the prior report (12.5% of float, 3.2 days to cover).

Market cap$9.39B282.6M shares

Revenue · quarter$263.7M+45.4% YoY

Diluted EPS$0.00—

P/E · TTM89.3×P/S 9.5×

Net margin-0.2%Gross 68.1%

Dividend yieldNone$0.3 last paid

52-week range14.55 – 36.14−8.1% from high

Volume4.1M1.19× 20-day avg

Volatility · 60d64.7%Annualised

Short % of float12.5%3.2 days to cover

Net cash$400.0MCash $793.1M

Next earnings—Not scheduled

Split-adjusted performance

1W −6.3%1M +21.0%3M +66.1%6M +73.7%YTD +23.1%1Y +11.0%3Y —5Y −40.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Medical Labs

Percentile among 24 companies (100 = best)

6-month momentum73

Revenue growth94

Net margin57

Value (low P/E)—

Size83

Industry medians: 6-month return +36.9%, revenue growth +25.0%, net margin −4.0%, P/E 32.4×.

Short interest

Details →

Shares short13.6M−2.2% vs prior

Days to cover3.2Settled Oct 15

% of float12.5%

Short vol. 10d43.1%of daily volume

Closest peers by size in Medical Labs

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
CAICaris Life Sciences	$33.22	+1.13%	+73.7%	+45.4%	−0.2%	89.3	$9.39B
GRALGRAIL	$143.66	+3.03%	+128.9%	+25.7%	−246.7%	—	$6.42B	Compare
RDNTRadNet	$80.26	+9.67%	+36.9%	+25.0%	1.2%	—	$6.32B	Compare
BLLNBillionToOne	$113.89	+3.11%	+39.9%	—	7.4%	—	$5.37B	Compare
CDNACareDx	$85.86	−2.95%	+309.8%	+39.3%	13.8%	35.1	$4.51B	Compare
VCYTVeracyte	$52.52	+4.43%	+27.5%	+15.5%	17.0%	36.9	$4.22B	Compare
GHGuardant Health	$168.58	−3.67%	+82.7%	+44.3%	−35.9%	—	$22.62B	Compare
CELCCelcuity	$69.24	−0.69%	−50.3%	—	—	—	$3.39B	Compare
DGXQuest Diagnostics	$255.68	+3.49%	+35.2%	+10.0%	10.0%	25.1	$28.22B	Compare

News about Caris Life Sciences

All news →

Caris Life Sciences,?Inc. (CAI) Q3 Earnings and Revenues Top EstimatesZacks Investment Research · 9h ago▲ Positive Analysts Estimate Caris Life Sciences,?Inc. (CAI) to Report a Decline in Earnings: What to Look Out forZacks Investment Research · Oct 28, 2026▼ Negative Cancer Test Maker Caris Life Sciences Unveils Breakthrough In Early Cancer Detection, Profit SurpriseBenzinga · Feb 27, 2026▲ Positive

Quick answers

What does Caris Life Sciences do?: Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
What is CAI's market cap?: $9.39B, based on the Nov 4 close of $33.22.
What is CAI's P/E ratio?: 89.3× trailing-twelve-month earnings of $105.14M.
Does Caris Life Sciences pay a dividend?: No regular cash dividend has been paid in the last year.
How much of CAI is sold short?: 13.6M shares, 12.5% of float, as of Oct 15, 2026.
What sector is CAI in?: Healthcare, in the Medical Labs industry.

About Caris Life Sciences

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

HQ: Irving, TX1,846 employeesListed Jun 18, 2025carislifesciences.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology